Evidence map›Paper›PMID 38740822›Full record

ArticleNature communications2024

Deep mutational scanning reveals a correlation between degradation and toxicity of thousands of aspartoacylase variants.

Martin Grønbæk-Thygesen, Vasileios Voutsinos, Kristoffer E Johansson, Thea K Schulze, Matteo Cagiada, Line Pedersen, Lene Clausen, Snehal Nariya, Rachel L Powell, Amelie Stein and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Functional dissection ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Supervised learning of protein variant effects across large-scale mutagenesis datasets.Protein science : a publication of the Protein Society · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. MaveMD: A functional data resource for genomic medicine.medRxiv : the preprint server for health sciences · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Martin Grønbæk-ThygesenLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Vasileios VoutsinosLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-0911-3648
Kristoffer E JohanssonLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-6054-0461
Thea K SchulzeLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-6587-6749
Matteo CagiadaLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-7281-5696
Line PedersenLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Lene ClausenLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Snehal NariyaDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.
Rachel L PowellDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-4791-6692
Amelie SteinDepartment of Biology, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-5862-1681
Douglas M FowlerDepartment of Genome Sciences, University of Washington, Seattle, WA, USA. dfowler@uw.edu.ORCID http://orcid.org/0000-0001-7614-1713
Kresten Lindorff-LarsenLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark. lindorff@bio.ku.dk.ORCID http://orcid.org/0000-0002-4750-6039
Rasmus Hartmann-PetersenLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark. rhpetersen@bio.ku.dk.ORCID http://orcid.org/0000-0002-4155-7791

Funding

Lundbeckfonden (Lundbeck Foundation) R209-2015-3283Lundbeckfonden (Lundbeck Foundation) R249-2017-510Lundbeckfonden (Lundbeck Foundation) R272-2017-452Natur og Univers, Det Frie Forskningsråd (Natural Sciences, Danish Council for Independent Research) 10.46540/2032-00007BNovo Nordisk Fonden (Novo Nordisk Foundation) NNF21OC0071057Novo Nordisk Fonden (Novo Nordisk Foundation) PRISM
6 · The paper itself

Abstract

Unstable proteins are prone to form non-native interactions with other proteins and thereby may become toxic. To mitigate this, destabilized proteins are targeted by the protein quality control network. Here we present systematic studies of the cytosolic aspartoacylase, ASPA, where variants are linked to Canavan disease, a lethal neurological disorder. We determine the abundance of 6152 of the 6260 ( ~ 98%) possible single amino acid substitutions and nonsense ASPA variants in human cells. Most low abundance variants are degraded through the ubiquitin-proteasome pathway and become toxic upon prolonged expression. The data correlates with predicted changes in thermodynamic stability, evolutionary conservation, and separate disease-linked variants from benign variants. Mapping of degradation signals (degrons) shows that these are often buried and the C-terminal region functions as a degron. The data can be used to interpret Canavan disease variants and provide insight into the relationship between protein stability, degradation and cell fitness.

Indexed as

AmidohydrolasesCanavan DiseaseProteolysisAmino Acid SubstitutionHEK293 CellsHumansMutationProteasome Endopeptidase ComplexProtein StabilityThermodynamicsUbiquitinAmidohydrolasesaspartoacylaseProteasome Endopeptidase ComplexUbiquitin

Identifiers

PMID38740822
PMCPMC11091098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.